The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
ADVIL DUAL ACTION WITH ACETAMINOPHEN Back Pain
Ibuprofen, Acetaminophen · IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg/1 · Tablet, Film Coated · Oral · Haleon US Holdings LLC
NDC 00573-0145-02 · 2 TABLET, FILM COATED in 1 POUCH · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for acetaminophen and ibuprofen (oral solid) in the next 90 days
price up 19% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- NDA211733
- TE code
- —
- Approval date
- Feb 28, 2020
- Patents / exclusivity
- 1 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11918693 | Jul 9, 2041 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Ibuprofen, Acetaminophen (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Haleon US Holdings LLC | IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| Navajo Manufacturing Company Inc. | IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Select Consumer Group | IBUPROFEN 125 mg/1; ACETAMINOPHEN 250 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Haleon US Holdings LLC | IBUPROFEN 250 mg/1; ACETAMINOPHEN 125 mg/1 | Jul 22, 2026 | Aug 21, 2026 |
| Navajo Manufacturing Company Inc. | IBUPROFEN 250 mg/1; ACETAMINOPHEN 125 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Select Consumer Group | IBUPROFEN 250 mg/1; ACETAMINOPHEN 125 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Haleon US Holdings LLC | ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1 | Jul 15, 2026 | Jul 19, 2026 |
| Navajo Manufacturing Company Inc. | ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Select Consumer Group | ACETAMINOPHEN 250 mg/1; IBUPROFEN 125 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "ADVIL DUAL ACTION WITH ACETAMINOPHEN Back Pain — NDC 00573-0145-02," retrieved September 3, 2026, https://drugdashboards.com/drug/00573014502.
Free to cite with attribution — see how the data is put together.